Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.08 (-16.67%)
Close on Nov 12, 2026Market cap $2.07MP/E –Yield –
Jaguar Health enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Jaguar Health's enterprise value was $158.28B on Jan 31, 2024, against $1,905.96T a year earlier. Over the last 5 years it ranged from $158.28B to $7,441.06T, with a median of $1,354.53T.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2024 | Jan 31, 2024 | $158.28B | -31.1% |
| 2023 | Dec 29, 2023 | $229.79B | -100.0% |
| 2022 | Jan 31, 2022 | $1,905.96T | -21.7% |
| 2021 | Dec 31, 2021 | $2,435.13T | +811.7% |
| 2020 | Jan 31, 2020 | $267.10T | -4.1% |
| 2019 | Dec 31, 2019 | $278.58T | -54.6% |
| 2018 | Jan 31, 2018 | $613.00T | -9.3% |
| 2017 | Dec 29, 2017 | $675.75T | -54.9% |
| 2016 | Dec 30, 2016 | $1,499.67T | +30.9% |
| 2015 | Dec 31, 2015 | $1,145.72T | – |
See a number that looks wrong?